Back to AVIVA PLC AVIVA PLC

AMLXAMLX
3 quarters

Position history for AVIVA PLCAVIVA PLC's holdings in AMYLYX PHARMACEUTICALS INC

No. Aviva exited its AMLX (Amylyx Pharmaceuticals) position in Q3 2024. Its Q2 2024 13F listed 363,032 shares worth $689,761. Aviva first reported AMLX in Q1 2024 and held it in 2 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$412,987

Total Shares Change

-145,418

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%$3.08
0
2024-Q2
Increased
363,032
+149.7%
$689,7610.0%$1.90
40
2024-Q1
New
145,418
-
$412,9870.0%$2.84
33

Other major holders of AMLX: FMR LLC, VIKING GLOBAL INVESTORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used